SciGlow uses cookies to provide you with a great user experience. By using this website, you agree to the use of cookies on your device.

Applied Physics Reviews

Ge Gao, Hyeok Kim, Byoung Soo Kim, Jeong Sik Kong, Jae Yeon Lee, Bong Woo Park, Su Hun Chae, Jisoo Kim, Kiwon Ban, Jinah Jang, Hun-Jun Park and Dong-Woo Cho

American Institute of Physics

Posted by Jean Ho
Jean covers medicine, wellness, and mental health.
Contact: health@sciglow.com

3D printing, bioinks create implantable blood vessels

A modified triple-coaxial 3D cell printing technique allows fabrication of multilayer blood vessels that have the unique biomolecules needed to transform into functional blood vessels when they are implanted.

4 weeks ago by American Institute of Physics

A biomimetic blood vessel was fabricated using a modified 3D cell printing technique and bioinks, which were formulated from smooth muscle cells from a human aorta and endothelial cells from an umbilical vein. The result is a fully functional blood vessel with a dual-layer architecture that outperforms existing engineered tissue and brings 3D-printed blood vessels several fundamental steps closer to clinical use.

The engineered blood vessels were grafted as abdominal aortas into six rats. Over the next several weeks, scientists observed a transformation in which the rat’s fibroblasts formed a layer of connective tissue on the surface of the implant to integrate the fabricated vessel graft as part of the existing, living tissue. The results, published in Applied Physics Reviews, from AIP Publishing, include details on the triple-coaxial 3D printing technology they developed and their analysis of the unique architecture, physical strengths and biological activity of the engineered tissue.

Triple-coaxial cell printing technology to construct biomimetic tissue-engineered blood vessels. Researchers in Asia used triple-coaxial cell printing technology to construct biomimetic tissue-engineered blood vessels that include an endothelium layer surrounded by a smooth muscle layer. The prematured blood vessels were evaluated in vivo through an interpositional abdominal aorta graft in a rat model. Credit: Gao et al.

“The artificial blood vessel is an essential tool to save patients suffering from cardiovascular disease,” author Ge Gao said. “There are products in clinical use made from polymers, but they don’t have living cells and vascular functions. We wanted to tissue-engineer a living, functional blood vessel graft.”

Prior attempts to construct small-diameter blood vessels have yielded blood vessels that are fragile and prone to blockage. They often use a stripped-down version of extracellular material, such as collagen-based bioinks. In contrast, material from a native blood vessel contains collagen plus a collection of diverse biomolecules that provide a favorable microenvironment for vascular cell growth.

Identifying the risk of recurrence of developmental disorder in future pregnancies

15 Jun 2019

Using these native-materials-based bioinks preserves the natural complexity of the blood vessel and accelerates the generation of functional vascular tissues, so they have enhanced strength and anti-thrombosis functions.

After fabrication, the printed blood vessel was matured in a lab that was designed to tune the vessel’s biological and physical characteristics to precise specifications of wall thickness, cellular alignment, burst pressure, tensile strength, and its ability to contract, mimicking natural blood vessel function.

The authors plan to continue to develop processes to increase the strength of the blood vessels closer to that of human coronary arteries. They also plan to perform long-term evaluation of vascular grafts, observing what happens as they continue to develop in place and become real tissue in the implanted environment.